{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-107064","form_type":"8-K","ticker":"PAHC","cik":"0001069899","company_name":"PHIBRO ANIMAL HEALTH CORP","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.715433+00:00","generated_at":"2026-05-17T00:09:57.906833+00:00","sec_items":["2.02","5.07","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Phibro Q1 net sales up 40% to $363.9M; raises FY2026 adjusted EBITDA guidance to $230-240M","bullets":["Net sales $363.9M (+40% YoY); net income $26.5M ($0.65 diluted EPS) vs $7.0M ($0.17) prior year.","Adjusted diluted EPS $0.73 (doubled from $0.35); adjusted EBITDA $61.9M (+$31.2M YoY).","Animal Health sales rose 55% to $283.5M, driven by acquired MFA portfolio (+$80.5M incremental).","FY2026 guidance: Adjusted EBITDA raised to $230-240M (28% growth); net sales reaffirmed $1.43-1.48B.","Company launched Restoris™ dental gel for dogs; annual meeting reelected all director nominees and approved say-on-pay every 3 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-107064","json":"https://secwatch.observer/filing/0001104659-25-107064.json","markdown":"https://secwatch.observer/filing/0001104659-25-107064.md","text":"https://secwatch.observer/filing/0001104659-25-107064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925107064/0001104659-25-107064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925107064/pahc-20251104x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:09:57.906833+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}